97 related articles for article (PubMed ID: 9316588)
1. Immunophenotype of human ovarian malignancies (cystadenocarcinomata and mixed müllerian tumor) established in SCID mice.
Schumacher U; Adam E; Dietl J; Horny HP
Exp Mol Pathol; 1997 Apr; 64(2):103-13. PubMed ID: 9316588
[TBL] [Abstract][Full Text] [Related]
2. [Establishment and comparison of two intraperitoneally transplanted human ovarian carcinoma models with immune reconstitution in severe combined immunodeficient mice].
Li Y; Cui H; Chang XH; Feng J; Fu TY; Feng YJ; Wei LH
Ai Zheng; 2004 Feb; 23(2):160-4. PubMed ID: 14960235
[TBL] [Abstract][Full Text] [Related]
3. Effects of IL-12 on human ovarian tumors engrafted into SCID mice.
Silver DF; Hempling RE; Piver MS; Repasky EA
Gynecol Oncol; 1999 Feb; 72(2):154-60. PubMed ID: 10021294
[TBL] [Abstract][Full Text] [Related]
4. Flt-3 ligand inhibits growth of human ovarian tumors engrafted in severe combined immunodeficient mice.
Silver DF; Hempling RE; Piver MS; Repasky EA
Gynecol Oncol; 2000 Jun; 77(3):377-82. PubMed ID: 10831345
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of cell lines derived from uterine malignant mixed Müllerian tumor.
Yuan Y; Kim WH; Han HS; Lee JH; Park HS; Chung JK; Kang SB; Park JG
Gynecol Oncol; 1997 Sep; 66(3):464-74. PubMed ID: 9299262
[TBL] [Abstract][Full Text] [Related]
6. [Development of intraperitoneally transplantated human ovarian carcinoma model with immune reconstruction in severe combined immunodeficient mice].
Zhu H; Ye D; Chen H; Lu W; Xie X
Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):630-3. PubMed ID: 12133487
[TBL] [Abstract][Full Text] [Related]
7. [Establishment and characterization of a human ovarian adenocarcinoma cell line OC-8611].
Huang JS
Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):416-8. PubMed ID: 2634538
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human ovarian carcinomas in a SCID mouse model.
Xu Y; Silver DF; Yang NP; Oflazoglu E; Hempling RE; Piver MS; Repasky EA
Gynecol Oncol; 1999 Feb; 72(2):161-70. PubMed ID: 10021295
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic analysis of ovarian and testicular Müllerian papillary serous tumors.
Carano KS; Soslow RA
Mod Pathol; 1997 May; 10(5):414-20. PubMed ID: 9160304
[TBL] [Abstract][Full Text] [Related]
10. [Biological properties of two newly established cell lines (RMUG-S, RMUG-L) from a human ovarian mucinous cystadenocarcinoma].
Sakayori M; Nozawa S; Udagawa Y; Chin K; Lee SG; Sakuma T; Iizuka R; Wada Y; Yoshida S; Takeda Y
Hum Cell; 1990 Mar; 3(1):52-6. PubMed ID: 2083224
[TBL] [Abstract][Full Text] [Related]
11. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.
Maxwell GL; Chandramouli GV; Dainty L; Litzi TJ; Berchuck A; Barrett JC; Risinger JI
Clin Cancer Res; 2005 Jun; 11(11):4056-66. PubMed ID: 15930340
[TBL] [Abstract][Full Text] [Related]
12. Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models.
Lee CH; Xue H; Sutcliffe M; Gout PW; Huntsman DG; Miller DM; Gilks CB; Wang YZ
Gynecol Oncol; 2005 Jan; 96(1):48-55. PubMed ID: 15589579
[TBL] [Abstract][Full Text] [Related]
13. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
[TBL] [Abstract][Full Text] [Related]
14. Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: a genetic study with special reference to histogenesis.
Jin Z; Ogata S; Tamura G; Katayama Y; Fukase M; Yajima M; Motoyama T
Int J Gynecol Pathol; 2003 Oct; 22(4):368-73. PubMed ID: 14501818
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers.
Verschraegen CF; Hu W; Du Y; Mendoza J; Early J; Deavers M; Freedman RS; Bast RC; Kudelka AP; Kavanagh JJ; Giovanella BC
Clin Cancer Res; 2003 Feb; 9(2):845-52. PubMed ID: 12576458
[TBL] [Abstract][Full Text] [Related]
16. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotype of human HT29 colon cancer cell metastases in the lungs of scid mice: spontaneous versus artificial metastases.
Mitchell BS; Horny HP; Adam E; Schumacher U
Invasion Metastasis; 1997; 17(2):75-81. PubMed ID: 9561026
[TBL] [Abstract][Full Text] [Related]
18. Serial transplantation of a heterologous, mixed Müllerian tumor in the nude (athymic) mouse: growth characteristics and morphology.
Centola GM; Bibro MC; Hoskins WJ
Invasion Metastasis; 1985; 5(1):42-9. PubMed ID: 2984135
[TBL] [Abstract][Full Text] [Related]
19. Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus.
Clement PB; Zubovits JT; Young RH; Scully RE
Int J Gynecol Pathol; 1998 Jul; 17(3):211-22. PubMed ID: 9656116
[TBL] [Abstract][Full Text] [Related]
20. Transplantation of a human ovarian cystadenocarcinoma into severe combined immunodeficient (SCID) mice--formation of metastases without significant alteration of the tumour cell phenotype.
Schumacher U; Adam E; Horny HP; Dietl J
Int J Exp Pathol; 1996 Oct; 77(5):219-27. PubMed ID: 8977374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]